trial summary · NCT05865379
Efficacy and Safety of BUFY01 Versus SVS20 in the Treatment of Dry Eye Disease
Efficacy and Safety of BUFY01 Versus SVS20 in the Treatment of Dry Eye Disease: a Non-inferiority Investigation
Trial record from the TrialBase DB dataset, status RECRUITING, condition Dry Eye Disease, sponsored by TRB Chemedica International SA. Facts below are exported values from the current release, not inferred or edited prose.
Summary
The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.
The goal of this interventional investigation is to compare BUFY01 with SVS20 in the treatment of patients with dry eye disease. The main questions it aims to answer are: * Is BUFY01 non-inferior to SVS20 in terms of signs of DED? * Is BUFY01 non-inferior to SVS20 in terms of symptoms of DED? Participants will be asked to: * Visit the trial site at 4 different timepoints * Use the allocated study treatment everyday until the end of the study (during 3 months) * Be examined by the investigator * Complete several questionnaires * Return unused study treatment. Researchers will compare BUFY01 to SVS20 to see if both study treatments provide similar effects on signs and symptoms of the disease, together with comparable safety.
Source record: https://clinicaltrials.gov/study/NCT05865379
Facts
| registry id | NCT05865379 |
|---|---|
| primary registry | clinicaltrials-gov |
| recruitment status | RECRUITING |
| phase | not reported |
| study type | INTERVENTIONAL |
| lead condition | Dry Eye Disease |
| sponsor | TRB Chemedica International SA |
| sponsor class | INDUSTRY |
| enrollment | 80 |
| start date | 2026-10-26 |
| primary completion | 2027-04 |
| completion | 2027-06 |
| results posted | not reported |
Conditions
- Dry Eye Disease
Interventions
- BUFY01 eye drops in single-dose containers
- SVS20 eye drops in single-dose containers
Countries
- Belgium
- France
Intervention types: DEVICE
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access; credited toward the licence.